Menu
← Oncology Approval Tracker
FDA DECISION ·
Bortezomib Injection (Accord)
bortezomib · Accord Healthcare
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Additional bortezomib injection product approved for adults with multiple myeloma or mantle cell lymphoma.
LAMPGEN ANALYSIS
Why it matters
The approval adds a specific presentation of the established proteasome inhibitor.
What research teams should watch
Verify product concentration, permitted route, and preparation before substitution in an order set.
PRIMARY RECORDS